📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

AARTIDRUGSPharmaceuticals

Aarti Drugs Ltd — Financial Ratios & Key Metrics

₹319.75

-3.05%

P/E Ratio19.07xIndustry: 31.77x

ROE12.69%Return on equity

ROCE13.09%Return on capital

Debt/Equity0.39Low debt

💎

Valuation & Profitability

P/E Ratio

19.07x

Industry Average P/E

31.77x

Dividend Yield

0.24%

Market Cap

₹3.80K (Cr)

Sales Growth 5Y

5.74%

Profit Growth 5Y

4.03%

EPS Growth 5Y

4.46%

OPM 5Y Avg

13.80%

📉

Price Returns

1 Month

-15.19%

3 Months

-11.30%

6 Months

-12.07%

1 Year

-9.61%

52W Low

₹312

Current

₹320

52W High

₹564

3% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹365

▼ Price below SMA 50 — Bearish

SMA 200

₹444

▼ Long-term downtrend

Volume Signal

175% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Aarti Drugs Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.